Zevalin and stem cell transplant Patient Reports February 12, 2012

Zevalin Side Effects Report #5924073-X
Zevalin side effect was reported by a Consumer or non-health professional from JAPAN on July 24, 2008. Female patient, 45 years of age, weighting 99.21 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, renal failure acute, sepsis , stem cell transplant, venoocclusive disease. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN, ISODINE, HACHIAZULE, SOLDEM, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 03/12/2008.

Zevalin Side Effects Report #5844596-1
Zevalin side effect was reported by a Physician from FRANCE on July 25, 2008. Male patient, 52 years of age, was diagnosed with mantle cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: culture stool positive, diarrhoea infectious, enterococcal infection, hypersensitivity, malaise, pseudomonas infection, refusal of treatment by patient, stem cell transplant, weight decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ARACYTINE, ETOPOSIDE, MELPHALAN, TRIFLUCAN, ZELITREX. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5218635-5
Zevalin side effect was reported by a Health Professional from NORWAY on Jan 05, 2007. Female patient was diagnosed with mantle cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: procedural complication, stem cell transplant, transient ischaemic attack. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISOLONE, VINCRISTINE, CARMUSTINE, ETOPOSIDE. Patient recovered.

Zevalin Side Effects Report #5059375-5
Zevalin side effect was reported by a Health Professional from BELGIUM on July 06, 2006. Female patient, 63 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: lung disorder, myopathy steroid, polyneuropathy, quadriparesis, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMIB, CARMUSTINE, ETOPOSIDE, ARACYTINE, MELPHALAN, METHYLPREDNISOLONE, MEROPENEM, ACYCLOVIR. Patient was hospitalized and became disabled. Patient recovered.


Zevalin Side Effects Report #4952853-6
Zevalin side effect was reported by a Consumer or non-health professional from GERMANY on Mar 09, 2006. Female patient, 63 years of age, weighting 163.1 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: depressed level of consciousness, dermatitis, hyporeflexia, lung infiltration, mucosal inflammation, obstructive airways disorder, pulmonary toxicity, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient recovered.

Zevalin Side Effects Report #5038983-1
Zevalin side effect was reported by a Physician from FRANCE on June 08, 2006. Male patient, 60 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: encephalopathy, herpes virus infection, respiratory failure, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with MABTHERA, ETOPOSIDE, ARACYTINE, MELPHALAN, PROZAC, MOPRAL, LASIX. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5201884-X
Zevalin side effect was reported by a Health Professional from BELGIUM on Dec 21, 2006. Female patient, 59 years of age, weighting 178.6 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: stem cell transplant, viral infection . Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, ARACYTINE, MELPHALAN, CLARITHROMYCIN, IPRATROPIUM BROMIDE, POTASSIUM GLUCONATE. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5424463-8
Zevalin side effect was reported by a Health Professional from BELGIUM on Aug 06, 2007. Female patient, 59 years of age, weighting 180.8 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: dermatitis, haemoglobin decreased, mucosal inflammation, platelet count decreased, respiratory failure, stem cell transplant, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, OMEPRAZOLE. Patient recovered.

Zevalin Side Effects Report #4977446-6
Zevalin side effect was reported by a Health Professional from BELGIUM on Mar 15, 2006. Female patient, 59 years of age, weighting 180.8 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: mucosal inflammation, respiratory failure, skin toxicity, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXAN, ETOPOSIDE, ARACYTINE, MELPHALAN. Patient recovered.


Zevalin Side Effects Report #4847027-3
Zevalin side effect was reported by a Health Professional from GERMANY on Nov 18, 2005. Female patient, 50 years of age, weighting 154.3 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, depression , eating disorder , gastrointestinal disorder, nausea , stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, HEPARIN, TRANXENE, LEXOMIL, AMIKLIN, PIPERACILLIN. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #4845817-4
Zevalin side effect was reported by a Health Professional from FRANCE on Nov 15, 2005. Male patient, 47 years of age, weighting 202.8 lb, was diagnosed with bone marrow conditioning regimen, non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: bone marrow failure, bone marrow toxicity, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with ACYCLOVIR, CASPOFUNGIN, AMPHOTERICIN B, HEPARIN, PANTOPRAZOLE, MORPHINE, NEFOPAM. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #4847579-3
Zevalin side effect was reported by a Health Professional from FRANCE on Nov 18, 2005. Male patient, 47 years of age, weighting 202.8 lb, was diagnosed with bone marrow conditioning regimen, non-hodgkin's lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: bone marrow failure, neutropenia, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with ACYCLOVIR, CASPOFUNGIN, AMPHOTERICIN B, HEPARIN, PANTOPRAZOLE, MORPHINE, NEFOPAM. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5063497-2
Zevalin side effect was reported by a Health Professional from FRANCE on July 06, 2006. Female patient, 44 years of age, weighting 198.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: bone marrow failure, haemodialysis, renal failure acute, stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, ARACYTINE, MELPHALAN, ALIZAPRIDE, BENZNIDAZOLE, TRAMADOL. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #4875774-6
Zevalin side effect was reported by a Health Professional from GERMANY on Dec 19, 2005. Male patient, 31 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute respiratory failure, capnocytophagia infection, lung disorder, sepsis , stem cell transplant. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ETOPOSIDE, ARACYTINE, MELPHALAN, NEFOPAM, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.


Zevalin Side Effects Report #4892096-8
Zevalin side effect was reported by a Health Professional from GERMANY on Jan 05, 2006. Male patient, 31 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute respiratory failure, capnocytophagia infection, haemoglobin decreased, lung disorder, platelet count decreased, sepsis , stem cell transplant, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ETOPOSIDE, ARACYTINE, MELPHALAN, NEFOPAM, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5872436-3
Zevalin side effect was reported by a Health Professional from FRANCE on Aug 19, 2008. Male patient, 60 years of age, was diagnosed with b-cell unclassifiable lymphoma high grade and was treated with Zevalin. After drug was administered, patient experienced the following side effects: atrial fibrillation , febrile bone marrow aplasia, ischaemia, mucosal inflammation, musculoskeletal pain, myopericarditis, pericardial effusion, stem cell transplant, tachycardia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #4895200-0
Zevalin side effect was reported by a Health Professional from GERMANY on Jan 09, 2006. Male patient, 47 years of age, weighting 189.6 lb, was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: acinetobacter bacteraemia, haematotoxicity, haemoglobin decreased, platelet count decreased, sepsis , stem cell transplant, white blood cell count decreased. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, ACYCLOVIR, CASPOFUNGIN, AMPHOTERICIN B, HEPARIN, PANTOPRAZOLE, MORPHINE. Patient recovered.

Zevalin Side Effects Report #5085171-9
Zevalin side effect was reported by a Physician from UNITED STATES on Aug 01, 2006. Male patient was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac murmur, cough, pyrexia, stem cell transplant, tachycardia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, BACTRIM. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5933661-6
Zevalin side effect was reported by a Health Professional from SPAIN on Oct 09, 2008. Male patient was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: aspergillosis, cytomegalovirus colitis, graft versus host disease, hypoxia, multi-organ failure, neutropenia, septic shock, stem cell transplant, tachycardia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, FLUDARABINE PHOSPHATE, MELPHALAN, FRAXIPARINE, OMEPRAZOLE, METHYLPREDNISOLONE, GANCICLOVIR, AMBISOME. Patient died on 10/01/2008.


Zevalin Side Effects Report #4866087-7
Zevalin side effect was reported by a Physician from UNITED STATES on Dec 07, 2005. Male patient was diagnosed with b-cell lymphoma and was treated with Zevalin. After drug was administered, patient experienced the following side effects: cardiac murmur, cough, heart rate increased, pyrexia, stem cell transplant, tachycardia. Zevalin dosage: unknown. During the same period patient was treated with RITUXIMAB, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5926713-8
Zevalin side effect was reported by a Health Professional from UNITED KINGDOM on Oct 01, 2008. Male patient was treated with Zevalin. After drug was administered, patient experienced the following side effects: acute myelomonocytic leukaemia, stem cell transplant. Zevalin dosage: unknown. Patient died on 04/26/2008.